Cranial neuralgia

Cranial neuralgia is a group of rare pain disorders characterized by sudden, severe, often shock-like or stabbing pain along the distribution of one or more cranial nerves. The most well-known form is trigeminal neuralgia (affecting cranial nerve V), but cranial neuralgias can involve other cranial nerves including the glossopharyngeal nerve (cranial nerve IX), the nervus intermedius (a branch of cranial nerve VII), and the occipital nerves. These conditions primarily affect the nervous system, with pain episodes typically triggered by everyday activities such as chewing, speaking, swallowing, or light touch to specific facial or head regions. Episodes may last from seconds to minutes and can recur frequently, significantly impairing quality of life. Cranial neuralgias can be classified as classical (caused by neurovascular compression, where a blood vessel presses on the nerve root), secondary (resulting from an underlying condition such as multiple sclerosis, tumors, or structural abnormalities), or idiopathic (no identifiable cause). Diagnosis is primarily clinical, based on the characteristic pattern and distribution of pain, and may be supported by MRI to identify structural causes or neurovascular compression. Treatment options include pharmacological therapy, with carbamazepine and oxcarbazepine being first-line medications particularly for trigeminal neuralgia. Other anticonvulsants such as gabapentin, pregabalin, and lamotrigine may also be used. For patients who do not respond adequately to medication, surgical interventions are available, including microvascular decompression, percutaneous procedures (balloon compression, glycerol rhizolysis, radiofrequency thermocoagulation), and stereotactic radiosurgery (Gamma Knife). The choice of treatment depends on the specific cranial nerve involved, the underlying etiology, patient age, and overall health status.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Cranial neuralgia